Work

[Study on the safety profile of dual plasma molecular adsorption system application in patients with liver failure and refractory hyperbilirubinemia].

Year: 2024

Type: other

Abstract: DPMAS clinical application is generally safe in patients with liver disease. The most common complications are bleeding, hypotension, allergic reactions, and infections, which need to be paid special attention and timely intervention to ensure the safety profile of treatment.

Source: PubMed

DOI: 10.3760/cma.j.cn501113-20240830-00410

Authors: X Q Lan, W C Xu, C Z Hong, M J Zhou, J Zhou, B L Li, J W Liu, Y Xu, F Y Zhou, J J Chen, Y Li, L Bai

Institutions: Nanfang Hospital, Southern Medical University, West China Hospital of Sichuan University

Language: English

Topic: Liver Disease and Transplantation

Subfield: Hepatology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: green

OpenAlex ID: W4406296823

Cites:

Cited by:

Related to: 10